Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yask Gupta

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nucleic Acids Research|May 7, 2014
The evolutionary dynamics of variant antigen genes in Babesia reveal a history of genomic innovation underlying host-parasite interactionAndrew P Jackson, Thomas D Otto, Alistair Darby, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 25, 2023
Mouse and human studies support DSTYK loss of function as a low-penetrance and variable expressivity risk factor for congenital urinary tract anomaliesJeremiah Martino, Qingxue Liu, Katarina Vukojevic, et al.
JAMA Network Open|March 11, 2026
Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective VariantElena Martinelli, Juntao Ke, Atlas Khan, et al.
Nature Communications|April 29, 2023
Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndromeAlexandra Barry, Michelle T McNulty, Xiaoyuan Jia, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Strong protective effect of the <i>APOL1</i> p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle McNulty, et al.
Nature Communications|November 30, 2023
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle T McNulty, et al.
The Journal of Clinical Investigation|March 28, 2023
CERT1 mutations perturb human development by disrupting sphingolipid homeostasisCharlotte Gehin, Museer A Lone, Winston Lee, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nucleic Acids Research|May 7, 2014
The evolutionary dynamics of variant antigen genes in Babesia reveal a history of genomic innovation underlying host-parasite interactionAndrew P Jackson, Thomas D Otto, Alistair Darby, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 25, 2023
Mouse and human studies support DSTYK loss of function as a low-penetrance and variable expressivity risk factor for congenital urinary tract anomaliesJeremiah Martino, Qingxue Liu, Katarina Vukojevic, et al.
JAMA Network Open|March 11, 2026
Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective VariantElena Martinelli, Juntao Ke, Atlas Khan, et al.
Nature Communications|April 29, 2023
Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndromeAlexandra Barry, Michelle T McNulty, Xiaoyuan Jia, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Strong protective effect of the <i>APOL1</i> p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle McNulty, et al.
Nature Communications|November 30, 2023
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle T McNulty, et al.
The Journal of Clinical Investigation|March 28, 2023
CERT1 mutations perturb human development by disrupting sphingolipid homeostasisCharlotte Gehin, Museer A Lone, Winston Lee, et al.
Pageof 4